Insulin Resistance and Hormones in NYC: Why Metabolic Health Is the Foundation of Hormonal Balance
In our clinical experience at Regen Health Physicians NYC, one of the most underappreciated connections in medicine is the relationship between insulin resistance and hormonal health. Patients who come in asking about testosterone, thyroid, or estrogen dominance often have a foundational metabolic issue that's driving or amplifying their hormonal symptoms.
What Is Insulin Resistance?
Insulin resistance occurs when cells become less responsive to the hormone insulin, requiring the pancreas to produce more of it to maintain normal blood glucose. Over time, chronically elevated insulin—hyperinsulinemia—disrupts a cascade of other hormonal systems.
This isn't a rare condition. Estimates suggest that upward of 40% of American adults have some degree of insulin resistance, and many have no idea because standard fasting glucose and even HbA1c can be normal while fasting insulin is already elevated.
How Insulin Resistance Disrupts Your Hormones
Sex Hormone Binding Globulin (SHBG)
High insulin suppresses liver production of SHBG—the protein that binds and regulates circulating sex hormones. Low SHBG means more free estrogen, which can drive estrogen dominance in women and accelerate aromatization of testosterone to estrogen in men.
Testosterone in Men
Men with insulin resistance typically have lower total and free testosterone, higher estrogen, and greater body fat—all of which compound each other. Testosterone replacement without addressing metabolic root causes often produces suboptimal results.
PCOS in Women
Polycystic ovary syndrome is fundamentally a metabolic-hormonal disorder. Hyperinsulinemia drives excess ovarian androgen production, disrupting the menstrual cycle and ovulation. Our hormone optimization approach for women with PCOS always starts with metabolic assessment.
Thyroid Function
Insulin resistance and metabolic syndrome are associated with impaired conversion of T4 (inactive thyroid hormone) to T3 (active form), reduced thyroid receptor sensitivity, and increased risk of autoimmune thyroiditis. Patients with subclinical hypothyroid symptoms but "normal" TSH often have this metabolic-thyroid connection.
Cortisol
Chronic hyperinsulinemia activates the HPA axis, driving cortisol dysregulation. Elevated cortisol further worsens insulin resistance—a vicious cycle that makes both conditions harder to treat without addressing both simultaneously.
The RHPNY Metabolic-Hormonal Assessment
At RHPNY, we don't evaluate hormones in isolation. A comprehensive assessment includes:
- Fasting insulin (not just glucose)—the earliest marker of insulin resistance
- HOMA-IR calculation
- Full sex hormone panel: total and free testosterone, estradiol, SHBG, DHT, LH, FSH
- Thyroid panel: TSH, free T4, free T3, reverse T3, thyroid antibodies
- Cortisol assessment: morning cortisol ± DUTCH test for diurnal pattern
- Inflammatory markers: hs-CRP, homocysteine, ferritin
This integrated picture allows us to identify whether a patient's hormonal symptoms are primary (arising from the glands themselves) or secondary to metabolic dysfunction.
Treatment: Fixing the Foundation First
For patients with significant insulin resistance, the most impactful hormonal intervention is often metabolic:
- Dietary change: Low-glycemic, whole food approaches with appropriate protein to restore insulin sensitivity
- Exercise prescription: Zone 2 cardio and resistance training are among the most potent insulin-sensitizing interventions available
- Metformin or berberine: Insulin sensitizers that also modulate AMPK signaling and have longevity data behind them
- Targeted supplements: Inositol, magnesium, alpha-lipoic acid, and berberine based on individual needs
- Peptide therapy: Certain peptides can support metabolic function and GLP-1 pathway signaling
Once metabolic function improves, many patients find their hormonal symptoms dramatically reduced—sometimes without needing exogenous hormone therapy at all.
When Hormone Therapy Is Still Warranted
In patients with true primary hypogonadism, menopause, or andropause, hormone optimization remains appropriate and beneficial. But even then, addressing insulin resistance improves the therapeutic window and reduces the dose of hormone therapy needed.
If you're experiencing symptoms of hormonal imbalance—fatigue, weight gain, poor recovery, libido changes, or cycle irregularity—and haven't had a thorough metabolic assessment, book a consultation with Dr. Dhaliwal. Understanding the metabolic-hormonal axis may be the missing piece in your care.
---
This article is for informational purposes only and does not constitute medical advice. Do not modify your current medications or hormone therapy without consulting your physician.
